Institutional investors purchased a net $1.0 million shares of SCLN during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 53.47% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NANTAHALA CAPITAL MANAGEMENT LLC Bought 588.3 Thousand shares of SciClone Pharmaceuticals ...